세계의 신경혈관 혈전 제거 기기 시장 : 제품 유형별, 최종 사용자별, 지역별 - 산업 분석, 규모, 점유율, 성장 및 동향 예측(2024-2031년)

Persistence Market Research presents an in-depth analysis of the global Neurovascular Thrombectomy Devices Market. Offering an in-depth analysis of market trends, growth drivers, challenges, and emerging opportunities, this study provides valuable insights into the neurovascular thrombectomy sector. It offers a detailed examination of the market, furnishing crucial statistics and projections delineating the market's trajectory from 2024 to 2031.

Key Insights:

• Neurovascular Thrombectomy Devices Market Size (2024): USD 741.7 Million
• Projected Market Value (2031): USD 1147.1 Million
• Global Market Growth Rate (CAGR 2024 to 2031): 6.42%

Neurovascular Thrombectomy Devices Market - Report Scope:

The Neurovascular Thrombectomy Devices Market encompasses a range of critical devices utilized in the treatment of acute ischemic stroke caused by large vessel occlusion. These devices include stent retrievers, aspiration catheters, and other adjunctive devices designed to restore blood flow in occluded cerebral arteries. The market serves hospitals, specialty clinics, and ambulatory surgical centers, offering advanced thrombectomy solutions to improve patient outcomes and reduce disability associated with stroke.

Market Growth Drivers:

The global Neurovascular Thrombectomy Devices Market is driven by several key growth factors. The increasing incidence of ischemic stroke, coupled with growing awareness about the benefits of endovascular thrombectomy procedures, fuels demand for advanced neurovascular devices. Technological advancements in thrombectomy devices, such as the development of next-generation stent retrievers and aspiration systems, enhance procedural efficacy and expand the eligible patient population for endovascular treatment. Moreover, collaborative efforts between medical device manufacturers, neurologists, and interventional radiologists drive innovation and adoption of thrombectomy devices, contributing to market growth.

Market Restraints:

Despite promising growth prospects, the Neurovascular Thrombectomy Devices Market faces challenges related to reimbursement policies, procedural complexities, and physician training. Variations in reimbursement coverage for thrombectomy procedures across different healthcare systems impact device adoption rates and hospital investment decisions, posing a barrier to market expansion. Furthermore, the specialized skills and infrastructure required for performing neurointerventional procedures necessitate ongoing training and education for healthcare professionals, limiting widespread access to thrombectomy services in certain regions.

Market Opportunities:

The Neurovascular Thrombectomy Devices Market presents lucrative opportunities driven by technological innovation, clinical research, and healthcare infrastructure development. Emerging trends such as telestroke networks, mobile stroke units, and prehospital stroke triage protocols enhance access to timely thrombectomy treatment, expanding the addressable patient population for neurovascular devices. Additionally, investments in artificial intelligence, robotics, and digital health solutions enable personalized stroke care delivery, facilitating precision medicine approaches and optimizing treatment outcomes. Moreover, strategic collaborations between medical device companies, academic research institutions, and regulatory agencies foster innovation and regulatory compliance, paving the way for market growth and product differentiation.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Neurovascular Thrombectomy Devices Market globally?
• How are technological advancements and clinical research shaping the evolution of neurovascular thrombectomy devices and procedures?
• What are the key challenges and opportunities facing market participants in the neurointerventional device segment?
• Which geographic regions and healthcare settings offer the highest growth potential for neurovascular thrombectomy devices?
• What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of neurovascular interventions?

Competitive Intelligence and Business Strategy:

Leading players in the global Neurovascular Thrombectomy Devices Market, including multinational medical device companies, neurovascular startups, and academic research institutions, focus on innovation, clinical evidence generation, and market expansion to gain a competitive edge. These companies invest in research and development to create novel thrombectomy devices, procedural techniques, and stroke care pathways aligned with clinical guidelines and patient preferences. Moreover, strategic partnerships with stroke centers, neurological societies, and healthcare policymakers enable device manufacturers to drive clinical adoption, reimbursement advocacy, and regulatory approval for neurointerventional therapies. Furthermore, emphasis on post-market surveillance, real-world evidence generation, and patient-reported outcomes fosters continuous improvement and value-based innovation in the dynamic landscape of neurovascular thrombectom

Key Companies Profiled:

• Medtronic Plc
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Johnson & Johnson Services, Inc.
• Penumbra Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Acandis GmbH
• Argon Medical Inc
• Others.

Neurovascular Thrombectomy Devices Market Segmentation

By Product

• Stent Retriever
• Aspiration Catheter

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Taxonomy
• 2.2. Market Definition
• 2.3. Market Definition by Product Type

3. Global Economic Outlook

• 3.1. Gross Domestic Product Type by Region & Country, 2006 - 2023
• 3.2. Global Healthcare Market Indicators

4. Market Opportunity Analysis

• 4.1. Macro-Economic Factors
• 4.2. Opportunity Analysis

5. Market Dynamics

• 5.1. Drivers
• 5.2. Restraints
• 5.3. Opportunities
• 5.4. Trends

6. Macroeconomic Assumptions

7. Key Inclusion

• 7.1. Regional Average Pricing Analysis
• 7.2. Reimbursement Scenario
• 7.3. Key Regulations

8. North America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
• 8.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 8.4.1. Stent Retriever
  • 8.4.2. Aspiration Catheter
• 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 8.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 8.6.1. Hospitals
  • 8.6.2. Neuro-Catheterization Labs
  • 8.6.3. Specialized Neurosurgery Centers
• 8.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 8.8. Market Attractiveness Analysis
  • 8.8.1. By Country
  • 8.8.2. By Product Type
  • 8.8.3. By End User
• 8.9. Drivers and Restraints: Impact Analysis

9. Latin America Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 9.1. Introduction
• 9.2. Regional Market Trends
• 9.3. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
  • 9.3.1. Brazil
  • 9.3.2. Mexico
  • 9.3.3. Rest of Latin America
• 9.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
• 9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 9.5.1. Stent Retriever
  • 9.5.2. Aspiration Catheter
• 9.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 9.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 9.7.1. Hospitals
  • 9.7.2. Neuro-Catheterization Labs
  • 9.7.3. Specialized Neurosurgery Centers
• 9.8. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 9.9. Market Attractiveness Analysis
  • 9.9.1. By Country
  • 9.9.2. By Product Type
  • 9.9.3. By End User
• 9.10. Drivers and Restraints: Impact Analysis

10. Europe Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
  • 10.2.1. Germany
  • 10.2.2. U.K
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Russia
  • 10.2.7. Poland
  • 10.2.8. Rest of Western Europe
• 10.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
• 10.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 10.4.1. Stent Retriever
  • 10.4.2. Aspiration Catheter
• 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 10.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 10.6.1. Hospitals
  • 10.6.2. Neuro-Catheterization Labs
  • 10.6.3. Specialized Neurosurgery Centers
• 10.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 10.8. Market Attractiveness Analysis
  • 10.8.1. By Country
  • 10.8.2. By Product Type
  • 10.8.3. By End User
• 10.9. Drivers and Restraints: Impact Analysis

11. Asia Pacific Excluding China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
  • 11.2.1. Japan
  • 11.2.2. India
  • 11.2.3. Australia and New Zealand
  • 11.2.4. ASEAN
  • 11.2.5. Rest of Asia Pacific
• 11.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
• 11.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 11.4.1. Stent Retriever
  • 11.4.2. Aspiration Catheter
• 11.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 11.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 11.6.1. Hospitals
  • 11.6.2. Neuro-Catheterization Labs
  • 11.6.3. Specialized Neurosurgery Centers
• 11.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 11.8. Market Attractiveness Analysis
  • 11.8.1. By Country
  • 11.8.2. By Product Type
  • 11.8.3. By End User
• 11.9. Drivers and Restraints: Impact Analysis

12. China Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 12.2.1. Stent Retriever
  • 12.2.2. Aspiration Catheter
• 12.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 12.4. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 12.4.1. Hospitals
  • 12.4.2. Neuro-Catheterization Labs
  • 12.4.3. Specialized Neurosurgery Centers
• 12.5. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By End User
• 12.7. Drivers and Restraints: Impact Analysis

13. Middle East and Africa Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2019-2023
  • 13.2.1. GCC Countries
  • 13.2.2. South Africa
  • 13.2.3. Rest of Middle East and Africa
• 13.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
• 13.4. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2019-2023
  • 13.4.1. Stent Retriever
  • 13.4.2. Aspiration Catheter
• 13.5. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
  • 13.6.1. Hospitals
  • 13.6.2. Neuro-Catheterization Labs
  • 13.6.3. Specialized Neurosurgery Centers
• 13.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 13.8. Market Attractiveness Analysis
  • 13.8.1. By Country
  • 13.8.2. By Product Type
  • 13.8.3. By End User
• 13.9. Drivers and Restraints: Impact Analysis

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis

• 16.1. Market Structure by Tier

17. Competition Analysis

• 17.1. Competition Dashboard
• 17.2. Competitors Deep Dive
  • 17.2.1. Medtronic Plc
    • 17.2.1.1. Overview
    • 17.2.1.2. Analyst Commentary
    • 17.2.1.3. Product Type and Technology Portfolio
    • 17.2.1.4. Channel Footprint
    • 17.2.1.5. Strategy
      • 17.2.1.5.1. Marketing Strategy
      • 17.2.1.5.2. Product Type Strategy
      • 17.2.1.5.3. Channel Strategy
  • 17.2.2. Stryker Corporation
    • 17.2.2.1. Overview
    • 17.2.2.2. Analyst Commentary
    • 17.2.2.3. Product Type and Technology Portfolio
    • 17.2.2.4. Channel Footprint
    • 17.2.2.5. Strategy
      • 17.2.2.5.1. Marketing Strategy
      • 17.2.2.5.2. Product Type Strategy
      • 17.2.2.5.3. Channel Strategy
  • 17.2.3. Teleflex Incorporated
    • 17.2.3.1. Overview
    • 17.2.3.2. Analyst Commentary
    • 17.2.3.3. Product Type and Technology Portfolio
    • 17.2.3.4. Channel Footprint
    • 17.2.3.5. Strategy
      • 17.2.3.5.1. Marketing Strategy
      • 17.2.3.5.2. Product Type Strategy
      • 17.2.3.5.3. Channel Strategy
  • 17.2.4. Terumo Corporation
    • 17.2.4.1. Overview
    • 17.2.4.2. Analyst Commentary
    • 17.2.4.3. Product Type and Technology Portfolio
    • 17.2.4.4. Channel Footprint
    • 17.2.4.5. Strategy
      • 17.2.4.5.1. Marketing Strategy
      • 17.2.4.5.2. Product Type Strategy
      • 17.2.4.5.3. Channel Strategy
  • 17.2.5. Johnson & Johnson Services, Inc.
    • 17.2.5.1. Overview
    • 17.2.5.2. Analyst Commentary
    • 17.2.5.3. Product Type and Technology Portfolio
    • 17.2.5.4. Channel Footprint
    • 17.2.5.5. Strategy
      • 17.2.5.5.1. Marketing Strategy
      • 17.2.5.5.2. Product Type Strategy
      • 17.2.5.5.3. Channel Strategy
  • 17.2.6. Penumbra Inc.
    • 17.2.6.1. Overview
    • 17.2.6.2. Analyst Commentary
    • 17.2.6.3. Product Type and Technology Portfolio
    • 17.2.6.4. Channel Footprint
    • 17.2.6.5. Strategy
      • 17.2.6.5.1. Marketing Strategy
      • 17.2.6.5.2. Product Type Strategy
      • 17.2.6.5.3. Channel Strategy
  • 17.2.7. Boston Scientific Corporation
    • 17.2.7.1. Overview
    • 17.2.7.2. Analyst Commentary
    • 17.2.7.3. Product Type and Technology Portfolio
    • 17.2.7.4. Channel Footprint
    • 17.2.7.5. Strategy
      • 17.2.7.5.1. Marketing Strategy
      • 17.2.7.5.2. Product Type Strategy
      • 17.2.7.5.3. Channel Strategy
  • 17.2.8. Edwards Lifesciences Corporation
    • 17.2.8.1. Overview
    • 17.2.8.2. Analyst Commentary
    • 17.2.8.3. Product Type and Technology Portfolio
    • 17.2.8.4. Channel Footprint
    • 17.2.8.5. Strategy
      • 17.2.8.5.1. Marketing Strategy
      • 17.2.8.5.2. Product Type Strategy
      • 17.2.8.5.3. Channel Strategy
  • 17.2.9. Acandis GmbH
    • 17.2.9.1. Overview
    • 17.2.9.2. Analyst Commentary
    • 17.2.9.3. Product Type and Technology Portfolio
    • 17.2.9.4. Channel Footprint
    • 17.2.9.5. Strategy
      • 17.2.9.5.1. Marketing Strategy
      • 17.2.9.5.2. Product Type Strategy
      • 17.2.9.5.3. Channel Strategy
  • 17.2.10. Argon Medical Inc
    • 17.2.10.1. Overview
    • 17.2.10.2. Analyst Commentary
    • 17.2.10.3. Product Type and Technology Portfolio
    • 17.2.10.4. Channel Footprint
    • 17.2.10.5. Strategy
      • 17.2.10.5.1. Marketing Strategy
      • 17.2.10.5.2. Product Type Strategy
      • 17.2.10.5.3. Channel Strategy

18. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031 By Region

• 18.1. Introduction / Key Findings
• 18.2. Historical Market Size (US$ Mn) Analysis By Region
  • 18.2.1. North America
  • 18.2.2. Latin America
  • 18.2.3. Europe
  • 18.2.4. Asia Pacific Excluding China
  • 18.2.5. China
  • 18.2.6. Middle East and Africa
• 18.3. Market Size (US$ Mn) Forecast By Region
• 18.4. Market Attractiveness Analysis By Region

19. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By Product Type

• 19.1. Introduction/Key Finding
• 19.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 19.2.1. Stent Retriever
  • 19.2.2. Aspiration Catheter
• 19.3. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
• 19.4. Market Attractiveness Analysis By Product Type

20. Global Neurovascular Thrombectomy Market Analysis 2019-2023 and Forecast 2024-2031, By End User

• 20.1. Introduction/Key Finding
• 20.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 20.2.1. Hospitals
  • 20.2.2. Neuro-Catheterization Labs
  • 20.2.3. Specialized Neurosurgery Centers
• 20.3. Market Size (US$ Mn) Forecast By End User, 2024-2031
• 20.4. Market Attractiveness Analysis By End User

21. Global Neurovascular Thrombectomy Devices Market Analysis 2019-2023 and Opportunity Assessment, 2024-2031

• 21.1. Market Value Analysis (US$ Mn)
• 21.2. Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology